Digitek Digoxin double thickness pill overdose
Wednesday, May 28, 2008
Mark & Associates, P.C. is currently representing victims of Digitek/digoxin overdose or toxicity due to pills containing twice the normal dose of active ingredient.
Digitek, sold under Bertek and UDL labels, and also known as Cardoxin, Lanoxicaps or Lanoxin, was recalled in a Class I nationwide recall announced April 25, 2008. Actavis Totowa LLC (formerly known as Amide Pharmaceutical, Inc.), manufactures Digitek for distributors Mylan Pharmaceuticals Inc. and UDL Laboratories.
Digitek is prescribed to treat heart failure and irregular heartbeat (arrhythmia). Tablets were sold with double the thickness as typical tablets, and it is suspected that these pills contained double the active ingredient.
The double strength pills may lead to digitalis toxicity in patients experiencing renal failure or in those patients with decreased tolerance to the drug.Kidney patients may experience nausea, vomiting, dizziness, low blood pressure, and serious heart problems including cardiac instability and bradycardia (slow heart rate).
Some serious side effects of Digoxin Digitek overdose are:
- Allergic reaction (difficulty breathing due to throat closing, lips, tongue or face swelling, hives on the skin)
- Headache
- Fainting
- Drowsiness
- Dizziness
- Irregular heartbeats
- Slow heartbeats
- Fast heartbeats
- Chest pain
- Vision problems including blurred vision, seeing yellow-green, seeing light halos around objects, light sensitivity
- Hallucinations
- Psychotic behavior
- Altered mental ability
Pharmacies are currently contacting patients who may have received the double thickness pills. If you or a loved one received these defective Digitek pills and suffered an adverse side effect, please contact us today for a free legal consultation about your case.
Mark & Associates can be reached day or night by calling 1-866-50-RIGHTS (1-866-507-4448) or by visiting our websites : youhaverights.com and digitekdigoxinlawsuit.com
Posted under: Dangerous Drugs